During the past decade, Miyanomori Memorial Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miyanomori Memorial Hospital" #1 collaborator was "Teijin Pharma Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Miyanomori Memorial Hospital" are "Atrial Fibrillation" (1 trials), "Hyperuricemia" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Miyanomori Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Miyanomori Memorial Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Febuxostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miyanomori Memorial Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Miyanomori Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Miyanomori Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miyanomori Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".